How to Buy Accolade Stock
Accolade Inc
Accolade, Inc. , together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.
Accolade stock last closed at $9.40, up 0.53% from the previous day, and has decreased 41.07% in one year. It has underperformed other stocks in the Health Information Services industry by 0.14 percentage points. Accolade stock is currently +48.5% from its 52-week low of $6.33, and -44.72% from its 52-week high of $17.01.
As of Apr 24, 2024, there are 77.41M ACCD shares outstanding. The market capitalization of ACCD is $727.63M. In the last 24 hours, 569,663 ACCD shares were traded.
How to Buy Accolade Stock
Wondering how to invest in Accolade stock? Here's how.
- Figure out where to buy Accolade stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Accolade stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Select your method of payment and add your information.
- Evaluate Accolade stock: The Accolade ticker symbol is ACCD. Is Accolade stock a good investment? Should you buy shares of ACCD? How do ACCD's underlying business fundamentals look? Do top analysts think Accolade is a good buy? Why has ACCD's stock price moved recently? (Hint: Our stock analysis website can help you understand if ACCD is a good stock to buy).
- Place your ACCD trade: Decide if you will purchase ACCD shares at the current market price or use a limit order to buy ACCD stock at a particular price.
- Get key alerts regarding your investment in ACCD: Create a watchlist to keep track of your new investment in Accolade shares.
Step 1: Figure out where to buy Accolade stock
You will need an online brokerage account in order to access the NASDAQ market and buy ACCD shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal details so you are able to buy ACCD today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on apps for stocks, you can securely and quickly fund your account:
Watch the video below if you need help depositing funds into your new investment account.
Step 4: Evaluate Accolade stock
Once you have chosen the best place to buy Accolade stock, it's crucial to evaluate their stock before you invest, so you actually comprehend the risk and opportunity.
Accolade Metrics
Fundamentals of Accolade
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ACCD's stock page.
What is the fair value of ACCD stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ACCD's fair value.
Using relative valuations ratios:
- ACCD may be undervalued based on its P/B ratio of 1.67x, relative to Health Information Services industry P/B ratio of 3.39x
You can access more valuation analysis on ACCD's stock here.
A look at ACCD Cashflows and Balance Sheet
Pros:
- There are more short-term assets than short-term liabilities on the ACCD balance sheet.
- There are more short-term assets than long-term liabilities on the ACCD balance sheet.
- ACCD has cash burn of 37467000. It has sufficient cash and short-term investments to cover this for at least one year.
- ACCD has $230.02M in cash and short term investments. This is enough to cover its annual cash burn of $37.47M.
Cons:
- ACCD has a relatively high debt to equity ratio of 0.81.
- ACCD profit margin has gone up by 0.98 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy ACCD stock
Out of 7 Wall Street analysts who give recommendations on ACCD, the consensus analyst rating on Accolade is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent ACCD Analyst Upgrades/Downgrades
Stan Berenshteyn, a top 35% analyst from Wells Fargo maintains ACCD with a hold rating and raises their ACCD price target from $10.00 to $12.00, on Jan 9, 2024.
John Ransom, a top 12% analyst from Raymond James maintains ACCD with a buy rating and raises their ACCD price target from $12.00 to $16.00, on Jan 9, 2024.
You can dig deeper into what analysts are saying on the Accolade stock forecast page.
ACCD Technical Indicators
ACCD Earnings
Last year, ACCD revenue was $388.49M. In the past 3 year, ACCD's revenue has increased by 114.4% per year. This was faster than the Health Information Services industry average of 19.73%.
Dig into ACCD's earnings and revenue performance here.
Latest Insiders Trades at ACCD
Over the last year, executives and large shareholders at ACCD have bought more shares than they have sold.
Stephen H. Barnes, Chief Financial Officer of ACCD, was the latest ACCD insider to sell. They sold $961.71 worth of ACCD shares on Apr 18, 2024.
Learn more about who owns ACCD shares here.
Can I rely on ACCD as an income stream?
No, Accolade doesn't provide an income stream by paying out dividends.
What do other traders have to say about ACCD?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your ACCD trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, use a limit order.
Press the Open button and eToro will place your order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your investment in ACCD
Now that you own some ACCD shares, you'll want to stay up-to-date on your new company.
Put ACCD on a watchlist to track the most important metrics related to your ACCD stock.
ACCD Feed
How to Buy Stock in Accolade
To summarize, here are the 6 steps you need to take to buy Accolade stock right now:
- Figure out where to buy Accolade stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Accolade stock
- Place your ACCD trade
- Get key alerts regarding your investment in ACCD
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Accolade, add ACCD to your watchlist below.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.